Skip to main content

Peer Review reports

From: ALAIN01—Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential

Original Submission
19 Sep 2015 Submitted Original manuscript
13 Nov 2015 Reviewed Reviewer Report - Katharine Harding
9 Dec 2015 Reviewed Reviewer Report - Craig S. Moore
22 Dec 2015 Author responded Author comments - Tobias Ruck
Resubmission - Version 2
22 Dec 2015 Submitted Manuscript version 2
7 Jan 2016 Reviewed Reviewer Report - Craig S. Moore
26 Feb 2016 Author responded Author comments - Tobias Ruck
Resubmission - Version 3
26 Feb 2016 Submitted Manuscript version 3
Publishing
2 Mar 2016 Editorially accepted
10 Mar 2016 Article published 10.1186/s12883-016-0556-9

You can find further information about peer review here.

Back to article page